OpenAlex | Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells

Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells

Work

Year: 2007

Type: article

Source: Cancer Chemotherapy and Pharmacology

Authors Fabio Fusi, Antonella Ferrara, Attila Zalatnai, Joséph Molnár, Giampietro Sgaragli +1 more

Institutions University of Siena, Semmelweis University, University of Szeged

Cites: 30

Cited by: 19

Related to: 10

FWCI: 0.165

Citation percentile (by year/subfield): 75.46

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

Open Access status: closed